GNLX
GENELUX Corp
$2.97
-0.05 (-1.66%)
At close · Jul 7
Market Cap
$133.18M
Shares
44,840,416
Price & Indicators
Indicators
Price
Panels
Event markers
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$2.97
Open$3.09
Day$2.94–3.09
52W$2.29–8.54
Avg vol 30d176K
Short int3.2M · 7.1% float · 20.9d
Short vol55%
Last earningsMar 25, 2025
DataJan 2023–Jul 2026
Filing10-Q · May 7
Equibles Rating
blended score · not investment advice
Overall
Sell
SellHoldBuy
Technical
Neutral
Momentum
Strong
Sentiment
Bearish
Fundamentals
Strong
Quant / Vol
Very High
Market backdrop
VIX 16.9 · calm
Equity put/call 0.86
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
−19%
below
Price vs 50-day avg
+2%
above
RSI (14)
52
neutral
MACD trend
Positive
52-week position
11%
near low
Momentum
relative strength
1-month return
+1%
trailing
6-month return
+12%
trailing
YTD return
−32%
this year
Relative strength
+5%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $3 › 200d $4 — 200d above 50d
Institutional flow
Distributing
-8% holders QoQ · +12 funds added
Insider flow
Distributing
Net -$77.9K over 90 days · 100% sells
Short interest
Rising
7.10% of float · ▲ +1.5% MoM · 20.9 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
71 holders — mid 3-yr range
Squeeze score
71
high risk · 0–100
Fundamentals
Revenue growth
0%
Y/Y
EPS growth
+9%
Y/Y
Free cash flow
$-26.4M
Balance sheet
$5.3M
net cash
Quant / Vol
risk profile
Volatility
85%
annualized · 1-yr
Max drawdown
−72%
past year
ATR
5.9%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Up next
FQ3-26 quarter ends
~Sep 30, 2026
Est
filed May 7, 2026
Technicals
trend & momentum for long-term holders Neutral
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
−19%
Bearish
Price vs 50-day avg
+2%
Bullish
RSI (14)
52
Neutral
MACD trend
Positive
Bullish
52-week position
11%
Bearish
Market signals — smart money & positioning
Bearish · 3 of 6
Trend (MA cross)
No cross
50d $3 › 200d $4 — 200d above 50d
Institutional flow
Distributing
-8% holders QoQ · +12 funds added
Insider flow
Distributing
Net -$77.9K over 90 days · 100% sells
Short interest
Rising
7.10% of float · ▲ +1.5% MoM · 20.9 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
71 holders — mid 3-yr range
Price context
position in its 52-week range
52-wk low $2
Now $3 · 11%
52-wk high $9
vs 200-day avg -19%
vs 50-day avg +2%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Biotechnology — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
GNLX
this stock
GENELUX Corp
|
$133.18M | -31.9% | +0.0% | — | 7.1% |
|
ONC
BeOne Medicines Ltd.
|
$446.53B | +1.7% | +22179.2% | 908.7 | 0.1% |
|
VRTX
Vertex Pharmaceuticals Inc / Ma
|
$126.50B | +9.9% | +46.2% | 29.6 | 1.8% |
|
REGN
Regeneron Pharmaceuticals, Inc.
|
$69.50B | -14.0% | +20.8% | 16.2 | 3.2% |
|
ARGX
Argenx SE
|
$57.20B | +8.8% | — | — | 2.4% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Smart Money
Financials
Filings
Earnings & Events
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| GNLX | +2.4% | +1.4% | +12.1% | -1.3% | -31.9% |
| SPY | +0.9% | +1.4% | +7.6% | +0.1% | +9.7% |
| vs SPY | +1.5% | 0.0% | +4.5% | -1.5% | -41.5% |